SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-077808
Filing Date
2022-03-17
Accepted
2022-03-17 07:24:38
Documents
13
Period of Report
2022-03-11
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K d325336d8k.htm   iXBRL 8-K 29480
  Complete submission text file 0001193125-22-077808.txt   209291

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA grna-20220311.xsd EX-101.SCH 3606
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE grna-20220311_def.xml EX-101.DEF 16380
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE grna-20220311_lab.xml EX-101.LAB 26580
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE grna-20220311_pre.xml EX-101.PRE 17104
7 EXTRACTED XBRL INSTANCE DOCUMENT d325336d8k_htm.xml XML 7105
Mailing Address 200 BOSTON AVENUE SUITE 3100 MEDFORD MA 02155
Business Address 200 BOSTON AVENUE SUITE 3100 MEDFORD MA 02155 (617) 616-8188
GreenLight Biosciences Holdings, PBC (Filer) CIK: 0001822691 (see all company filings)

IRS No.: 851914700 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39894 | Film No.: 22746721
SIC: 2836 Biological Products, (No Diagnostic Substances)